(Q43450774)

English

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker

scientific article published in April 2009

Statements

Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker (English)
Ariane Sadr-Nabavi
Juliane Volkmann
Heide Hellebrand
Rene Kreutzfeld
Dieter Niederacher

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit